Filing Details
Sunshine Biopharma Inc. (NASDAQ:SBFM) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event.
8k filedNASDAQ:SBFM
Sunshine Biopharma Inc. (SBFM) Reports Material Event to SEC
Filing Details Sunshine Biopharma Inc. (NASDAQ:SBFM) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event. Market Context…
Market Context
Sunshine Biopharma Inc.'s stock currently trades at $1.17 with a market capitalization of $7.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Sunshine Biopharma Inc.'s stock.
All SEC filings for Sunshine Biopharma Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SBFM Stock Page
Frequently Asked Questions
Where can I read SBFM's SEC filings?
Browse all filings on our SBFM SEC filings page.
What types of SEC filings does Sunshine Biopharma Inc. file?
Public companies like Sunshine Biopharma Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.